CMS’ proposed changes to the Medicare Shared Savings Program (MSSP) doesn’t represent a major shift in policy stance toward accountable care organizations (ACOs), said Joe Antos, PhD, the Wilson H. Taylor Resident Scholar in Health Care and Retirement Policy at the American Enterprise Institute.
CMS’ proposed changes to the Medicare Shared Savings Program (MSSP) doesn’t represent a major shift in policy stance toward accountable care organizations (ACOs), said Joe Antos, PhD, the Wilson H. Taylor Resident Scholar in Health Care and Retirement Policy at the American Enterprise Institute.
Transcript
If the proposed CMS changes to the MSSP are expected to make fewer ACOs participate, do you think the proposal will affect the ACO movement?
I wouldn’t say that this is a major change in policy with regard to ACOs. The current administration has clearly accepted the concept of ACOs, they’re clearly trying to promote them in a way.
I would say that Andy Slavitt, who was the CMS administrator under [President] Obama, said something to the effect of “yeah, there should be a time limit and if you’re not successful within a reasonable time limit, then you should go. Because it’s not going to work out for you.” So, I think that’s kind of a hard-eyed business look at this. But I don’t think this is a major change in policy.
They’re going to have to do other things to either strongly promote ACOs or strongly discourage them. I think one of the things that would promote ACOs or promote movement toward a more sensible approach to delivery, in general, would be to follow some of MedPAC [Medicare Payment Advisory Commission]’s suggestions with regard to fixing MIPS [Merit-based Incentive Payment System] and fixing MACRA [Medicare Access and CHIP Reauthorization Act], which is a problem all by itself.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen